IV Ketamine Testimonials

Life changing testimonials from just a few of our patients….

Promising Help For Treatment Resistant Depression

What Is IV Ketamine Infusion Therapy?

Doctors at Yale University discovered that in tiny doses, FDA Approved Ketamine that is delivered via IV infusion, has been effective in relieving treatment resistant depression (TRD), Anxiety, OCD, PTSD, Phantom Pain, Trigeminal Neuralgia, RSD, Fibromyalgia, Migraines, and Neuropathy.

  • If you haven’t had success in finding relief, IV Ketamine Therapy may be right for you.
  • Experts from The National Institute of Mental Health have said, “IV Ketamine Therapy may be the most important treatment breakthrough in decades”.

The Ketamine Institute Of Michigan offers supervised IV Ketamine infusions. After a cleared medical history, you can begin treatment sessions right away. You will be under the care of Dr. Julia Aharonov, a Board Certified Anesthesiologist and her capable and experienced medical team. Each session should be less than a few hours. IV Ketamine therapy has no addictive properties.

Read All About Our IV Ketamine Infusion Therapy — This treatment could change your life!

Call: 855-KETAMINE

(855) 538-2646 or contact us to learn more about our IV Ketamine Infusion Treatments

Our Doctor

dr-julia-aharonov of the ketamine institute of michigan

Dr. Julia Aharonov has perfected a special IV Ketamine Therapy that truly helps patients who have been suffering from treatment resistant depression, bi-polar disorder and many forms of chronic pain, including fibromyalgia. Read more about Dr. Aharonov and her life changing procedure, then contact her to learn if IV Ketamine Therapy can help you.

FAQ’s

1. What Is Ketamine?

Ketamine was first synthesized in 1962 by Calvin L. Stevens, a professor of Chemistry at Wayne State University and a Parke Davis consultant conducting research on alpha-hydroxyimine rearrangements. Following FDA approval in 1970, ketamine anesthesia was first given to American soldiers during the Vietnam War, due to its safety. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.

Source: Wikipedia

2. Does Ketamine Infusion Therapy Really Help Treat Depression?

The American Psychiatric Association Council of Research Task Force on Novel Biomarkers and Treatments found that the data from 7 published placebo-controlled, double-blind, randomized clinical studies on Ketamine hydrochloride infusion therapy in the treatment of depression comprising 147 treated patients provide “compelling evidence that the antidepressant effects of ketamine infusion are both rapid and robust, albeit transient.”

Reports of Ketamine’s unique antidepressant effects, combined with frequent media coverage promulgating the potential benefits of Ketamine treatment, have generated substantial interest and optimism among patients, families, patient advocacy groups, and clinicians alike.

Read more about how Ketamine is used for treating depression.

Source: American Medical Association

3. How does IV Ketamine Therapy work?

The experts are not exactly sure how it helps with depression, but they have a basic idea. Ketamine is believed to change the method of communication between brain cells.

New studies show that Ketamine may have an extended impact on depression, even though Ketamine is only in the body for a short period of time.

Ketamine is believed to interact with opioid receptors, in the brain, which affect pain and depression.

Source: Web MD

4. How much does Ketamine Infusion Therapy cost?

We have created a clear, affordable tiered pricing structure for our patients. Click here for our IV Ketamine Infusion Pricing

Ketamine Treatment In the News

January 5, 2021: Repeated Ketamine Infusions Reduce PTSD Symptom Severity

Repeated intravenous (IV) ketamine infusions significantly reduce symptom severity in individuals with chronic post-traumatic stress disorder (PTSD) and the improvement is rapid and maintained for several weeks afterwards, according to a study conducted by researchers from the Icahn School of Medicine at Mount Sinai…